Cyclopentolate Eye Drops
Developed to support eye examinations, this solution is indicated to induce pupil dilation and cycloplegia for clearer assessment of the eye.
Strengths: 1%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Mydrilate
- Therapeutic class
Cycloplegic agent
- Pharmacological class
Anticholinergic
- Contraindications
hypersensitivity to cyclopentolate; narrow-angle glaucoma
- Minor side effects
stinging; blurred vision; photophobia
- Moderate side effects
increased intraocular pressure
- Dosage forms
Eye drops, solution
- Administration route
Ocular use
- Prescription status
POM
- Manufacturer
Thea
- Onset Time
30–60 minutes
- Duration
6–24 hours
- Storage instructions
Store in a cool place, keep tightly closed.
- Age restrictions
Use with care in young children.
- Pregnancy and breastfeeding
Consult a healthcare professional.
Precautions and warnings
may cause blurred vision; do not drive after administration; use with caution in children
Serious side effects
systemic toxicity — requires immediate medical attention; hallucinations — requires immediate medical attention
Patient summary
Developed to support eye examinations, this solution is indicated to induce pupil dilation and cycloplegia for clearer assessment of the eye.
Mechanism of action
Cyclopentolate is an anticholinergic agent that blocks the muscarinic receptors of the sphincter muscle of the iris and the ciliary muscle, causing temporary paralysis of accommodation and pupillary dilation.
Cyclopentolate Eye Drops
Developed to support eye examinations, this solution is indicated to induce pupil dilation and cycloplegia for clearer assessment of the eye.
Editorial Notes
- Active ingredient(s): Cyclopentolate
- Listed indication(s): Mydriasis, Cycloplegia